"Сейчас Центр решает крайне актуальные задачи сохранения и укрепления здоровья россиян, снижения заболеваемости и смертности от основных хронических неинфекционных заболеваний. Научные сотрудники НМИЦ ПМ проводят эпидемиологический мониторинг основных факторов риска сердечно-сосудистых заболеваний, создают и внедряют новые методы и организационные формы первичной и вторичной профилактики хронических неинфекционных заболеваний, участвуют в разработке и реализации стратегии действий по созданию в России единой профилактической среды."

During the past decade, National Research Center For Preventive Medicine conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Research Center For Preventive Medicine" #1 sponsor was "National Research Center for Preventive Medicine" with 5 trials, followed by "National Medical Research Center for Therapy and Preventive Medicine" with 4 trials sponsored, "Kowa Research Europe" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Kowa Research Institute, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Research Center For Preventive Medicine" #1 collaborator was "Moscow State University of Medicine and Dentistry" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "I.M. Sechenov First Moscow State Medical University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "National Research Center For Preventive Medicine" are "Atrial Fibrillation" (3 trials), "Dyslipidemia" (3 trials), "Adherence, Patient" (2 trials), "Hypercholesterolemia" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "National Research Center For Preventive Medicine" in a lesser frequency.

Most popular intervention types in "National Research Center For Preventive Medicine" are "Drug" (12 trials), "Other" (3 trials), "Behavioral" (2 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (4 trials), "Placebo" (4 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Research Center For Preventive Medicine" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Research Center For Preventive Medicine". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in National Research Center For Preventive Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Research Center For Preventive Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".